iA Global Asset Management Inc. Sells 5,183 Shares of HCA Healthcare, Inc. $HCA

iA Global Asset Management Inc. trimmed its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 12.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,638 shares of the company’s stock after selling 5,183 shares during the quarter. iA Global Asset Management Inc.’s holdings in HCA Healthcare were worth $17,812,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Brighton Jones LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC grew its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares in the last quarter. Sivia Capital Partners LLC lifted its position in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the period. Jump Financial LLC bought a new position in shares of HCA Healthcare in the second quarter worth $2,073,000. Finally, Sei Investments Co. lifted its position in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after purchasing an additional 49,214 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently commented on HCA shares. KeyCorp dropped their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Leerink Partners lowered their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Wells Fargo & Company dropped their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research report on Monday, April 27th. Finally, Robert W. Baird lowered their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Fifteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $503.00.

View Our Latest Stock Analysis on HCA

HCA Healthcare Stock Down 0.6%

NYSE HCA opened at $390.10 on Wednesday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The business’s fifty day moving average is $404.81 and its 200 day moving average is $463.96. The company has a market cap of $86.54 billion, a price-to-earnings ratio of 13.41, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the business posted $6.45 earnings per share. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th were given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.